HPLC analysis of the novel antipsychotic drug quetiapine in human plasma
- 26 September 2002
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 30 (4) , 969-977
- https://doi.org/10.1016/s0731-7085(02)00395-3
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) studyClinical Therapeutics, 2001
- Clinical Pharmacokinetics of QuetiapineClinical Pharmacokinetics, 2001
- Review of quetiapine and its clinical applications in schizophreniaExpert Opinion on Pharmacotherapy, 2000
- Atypical antipsychotic agents: A critical reviewAmerican Journal of Health-System Pharmacy, 2000
- Drug metabolism and atypical antipsychoticsEuropean Neuropsychopharmacology, 1999
- Analysis and pharmacokinetics of quetiapine and two metabolites in human plasma using reversed-phase HPLC with ultraviolet and electrochemical detectionJournal of Pharmaceutical and Biomedical Analysis, 1999
- QuetiapineCNS Drugs, 1998
- Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placeboBiological Psychiatry, 1997
- Quetiapine in Patients With SchizophreniaArchives of General Psychiatry, 1997
- Quetiapine (‘Seroquel’); an effective and well-tolerated atypical antipsychoticInternational Journal of Psychiatry in Clinical Practice, 1997